Oscar Health (OSCR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
9 Jul, 2026Executive summary
Achieved strong Q1 2025 results with total revenue up 42% year-over-year to $3.05 billion and membership reaching approximately 2 million, reflecting a 41% increase and strong retention.
Net income attributable to Oscar Health, Inc. increased 55% year-over-year to $275.3 million, driven by higher premium revenue and improved operating leverage.
Enhanced digital engagement, operational efficiency, and new technology features contributed to improved member experience and cost management.
Launched Oscar Community Resources and AI-driven care guides, and introduced live chat for Virtual Urgent Care.
Financial highlights
Premium revenue increased 43% year-over-year to $2.996 billion, with total revenue at $3.05 billion, primarily due to higher membership.
Net income reached $275.3 million, up from $177.4 million in Q1 2024.
Adjusted EBITDA was $329 million, up approximately $110 million year-over-year.
Earnings from operations grew to $297.1 million, up from $185.6 million in Q1 2024.
SG&A expense ratio dropped to 15.8%, a 260 basis point improvement and the lowest in company history.
Outlook and guidance
Reaffirmed full-year 2025 guidance: total revenue expected at $11.2–$11.3 billion.
Full-year MLR expected in the range of 80.7%–81.7%.
SG&A expense ratio guidance remains at 17.6%–18.1%.
Earnings from operations projected at $225–$275 million; adjusted EBITDA expected to be $140 million higher.
Membership expected to trend up in the first half, then down in the second half, ending near 1.8 million.
Anticipates lower Special Enrollment Period (SEP) membership growth in 2025 compared to 2024.
Expects potential headwinds from the expiration of enhanced APTCs and new CMS Program Integrity Rules.
Latest events from Oscar Health
- AI, transparency, and financial incentives are reshaping consumer-driven healthcare strategies.OSCR
7th Annual Healthcare Symposium9 Jul 2026 - 2025 revenue up 28% with record membership; 2026 targets profitability and margin gains.OSCR
Q4 20258 Jul 2026 - Three-year plan targets 20% revenue CAGR, 5% margin, and ICHRA-driven growth, powered by technology.OSCR
Investor Day 20248 Jul 2026 - Strong 2026 performance, favorable trends, and AI-driven integrity shape a stable outlook.OSCR
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - Board transitions, robust growth, and all proposals approved; no Q&A from shareholders.OSCR
AGM 20264 Jun 2026 - Revenue and net income soared, membership surged, but regulatory risks persist.OSCR
Q1 20267 May 2026 - Proxy covers director elections, say-on-pay, auditor ratification, and robust governance practices.OSCR
Proxy filing23 Apr 2026 - Votes will be cast on directors, executive pay, and auditor ratification at the June 2026 meeting.OSCR
Proxy filing23 Apr 2026 - Strong 2026 enrollment and robust risk management drive optimism amid regulatory shifts.OSCR
47th Annual Raymond James Institutional Investor Conference2 Mar 2026